First Wave BioPharma Inc. (FWBI) currently has a stock price of $0.60. The stock saw a sharp increase in the last trading session, hitting a high of $0.4448 after opening at $0.3972. The lowest recorded price for the day was $0.383 before it closed at $0.44.
The market performance of First Wave BioPharma Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $20.65 on 10/05/22, with the lowest value for the same timeframe being $0.27, recorded on 09/05/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of FWBI Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. First Wave BioPharma Inc.’s current trading price is -97.08% away from its 52-week high, while its distance from the 52-week low is 120.27%. The stock’s price range during this period has fluctuated between $0.27 and $20.65. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 107.54 million for the day, which was evidently higher than the average daily volume of 1.52 million over the last three months.
Financial Performance and Market Capitalization
First Wave BioPharma Inc. (FWBI) has experienced a quarterly decline of -65.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.31M and boasts a workforce of 10 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3563, with a change in price of -2.1042. Similarly, First Wave BioPharma Inc. recorded 2,876,778 in trading volume during the last 100 days, posting a change of -75.96%.
FWBI Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for FWBI stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.00.
FWBI Stock Stochastic Average
First Wave BioPharma Inc.’s raw stochastic average for the past 50 days is currently at 31.48%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 46.91%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 34.29% and 29.03%, respectively.
FWBI Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -90.18%.However, over the last six months, we can see a stronger performance of -79.80%. Over the last 30 days, the price of FWBI has fallen by 42.22%. And in the last five days, it has surged by 31.21%.
